Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study

Recently, the European LeukemiaNet (ELN) revised its genetic-risk classification of acute myeloid leukemia (AML). We categorized 1637 adults with AML treated with cytarabine/anthracycline regimens according to the 2022 and 2017 ELN classifications. Compared with the 2017 ELN classification, 2022 fav...

Descripción completa

Detalles Bibliográficos
Autores principales: Mrózek, Krzysztof, Kohlschmidt, Jessica, Blachly, James S., Nicolet, Deedra, Carroll, Andrew J., Archer, Kellie J., Mims, Alice S., Larkin, Karilyn T., Orwick, Shelley, Oakes, Christopher C., Kolitz, Jonathan E., Powell, Bayard L., Blum, William G., Marcucci, Guido, Baer, Maria R., Uy, Geoffrey L., Stock, Wendy, Byrd, John C., Eisfeld, Ann-Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079544/
https://www.ncbi.nlm.nih.gov/pubmed/36823396
http://dx.doi.org/10.1038/s41375-023-01846-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079544/
https://www.ncbi.nlm.nih.gov/pubmed/36823396
http://dx.doi.org/10.1038/s41375-023-01846-8

Ejemplares similares